Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials - Wikidata - awgldk - TriplyDB

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

http://www.wikidata.org/entity/Q33398018

about

Advances in chemotherapy for pancreatic cancer Evolution of systemic therapy for advanced pancreatic cancer.Personalising pancreas cancer treatment: When tissue is the issue.Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer.Protonation preferentially stabilizes minor tautomers of the halouracils: IRMPD action spectroscopy and theoretical studies.Adjuvant therapy in pancreatic cancer.Impact of dihydropyrimidine dehydrogenase and γ-glutamyl hydrolase on the outcomes of patients treated with gemcitabine or S-1 as adjuvant chemotherapy for advanced pancreatic cancer.Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy.Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma.Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base.Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review Looking to the future: biomarkers in the management of pancreatic adenocarcinoma.Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma.Deploying mouse models of pancreatic cancer for chemoprevention studies Use of a novel herbal medicine in a 75-year-old woman with multi-metastatic pancreatic cancer: A case report and review of the literature.Is tumour size an underestimated feature in the current TNM system for malignancies of the pancreatic head?Pre-operative cardiopulmonary exercise testing predicts adverse post-operative events and non-progression to adjuvant therapy after major pancreatic surgery Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC Adjuvant and neoadjuvant treatment in pancreatic cancer Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy.A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma.Current knowledge on pancreatic cancer.Pancreatic adenocarcinoma: Outstanding problems.Pancreatic Cancer: Current Options for Diagnosis, Staging and Therapeutic Management CXCR4 expression predicts early liver recurrence and poor survival after resection of pancreatic adenocarcinoma.Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients' quality of life Meta-analyses of treatment standards for pancreatic cancer.The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancer Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer.Accomplishments in 2008 in the treatment of metastatic pancreatic cancer.Accomplishments in 2008 in the management of localized pancreatic cancer.Survival outcomes in patients with early stage, resected pancreatic cancer - a comparison of gemcitabine- and 5-fluorouracil-based chemotherapy and chemoradiation regimens.Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer.Drugs in preclinical and early-stage clinical development for pancreatic cancer.New biomarkers and targets in pancreatic cancer and their application to treatment.Adjuvant therapy for pancreas adenocarcinoma.

P2860

Q28085711-23A79B6A-FA39-4221-A2EB-602111BB3DDB Q33557413-F23506BC-EC67-41D8-8816-7096A6FFEDF3 Q33801384-C8614EDD-09AB-4FCF-8532-2238691B1DE9 Q34297701-7E3FD1A2-FBE0-4D18-9B64-2D638B2BEB56 Q34347434-C8090474-E7D1-42D2-BC04-89CFA7D3019C Q34405072-B3EC47DD-284A-4828-A4EE-DDBAB30A0F3A Q34414547-4450D8AA-C9F1-45D4-87A9-05E929FAFA2F Q34538828-4022983F-0593-4A04-B384-31C1C35CCF58 Q34542396-5F898756-1DC7-40D3-B4E4-75C7A132D499 Q34661643-EFBBC9B4-A5DF-45A9-9292-A0F3F7316904 Q34680864-BE80A410-BBA8-47DC-84E7-0E55AFD34CF9 Q34774546-23D07737-964B-4071-8A90-492AB083B68A Q34993085-C491FA45-8774-470C-97C0-80FFD5DA97BF Q35202177-2D16F1AD-700A-43B7-BDB9-2166CC5E4201 Q35297202-9FFE6F60-50BF-46D0-B725-D775A738C722 Q35504794-C374CBCE-5582-4964-8718-F0246CF22C4B Q35622126-C6C163C0-00FD-4EB2-9DB4-D1BB8874A716 Q35803650-DAEA600F-BF9C-49FF-8A9F-C56EE1178F38 Q35854755-07133351-81F0-4DD2-B1C5-C651ACDAE90F Q35854766-73C59086-3C56-43F8-B37C-134DEFE17C24 Q35881178-325FE50B-7CB3-41AD-A012-83D152677D26 Q35886631-4B8FAA22-21AE-48E4-8550-265BF8B99828 Q35890548-A87BD74E-D7AA-4616-8C39-B2803B6412F0 Q35903399-005335B9-3401-4FC7-B75C-C299175B08CB Q35971808-BDBA162F-3041-4288-9C30-6371338EC5AD Q35998943-23292BE1-69E0-4E32-ADFC-1B9B34E88FE9 Q36281575-99FCB1AA-5220-4EA6-A4EC-DBF647596443 Q36299200-15115278-097E-4B28-9A07-12A00DE1A328 Q36544488-71F6BF56-8660-4DEC-9A5E-9942ADA3CE4D Q36640493-7A469C9B-4E62-4091-AA5D-70A5A51D122C Q36773130-8CC006EF-D8FB-483D-8DDA-51D6780DD7A6 Q37197012-9012C12B-D940-493C-8C75-C74E22D2BBBC Q37345350-8C9AAE51-B5F5-4F5E-BF16-33E5F9BC9B43 Q37468871-C1F4247A-B221-4CDD-BB25-A874840008E2 Q37468883-1B878C50-5AF9-486D-B491-A20C1A25B0EB Q37719839-03218A59-9915-4D81-98A9-DE67D92BBF2B Q37812010-2AA58FFE-4267-4FAF-9ED3-37D43700C576 Q37973133-4EF5863E-10DC-41A5-8F32-CE689129610F Q38021692-608585F8-1390-4378-B7FD-145E190C2B03 Q38034110-8CA33A0C-B3F6-4887-9569-A5C8489CD266

P2860

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

http://www.wikidata.org/entity/Q33398018

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Adjuvant 5-fluorouracil and fo ...... the ESPAC-1 and -3(v1) trials

@ast

Adjuvant 5-fluorouracil and fo ...... the ESPAC-1 and -3(v1) trials

@en

type

label

Adjuvant 5-fluorouracil and fo ...... the ESPAC-1 and -3(v1) trials

@ast

Adjuvant 5-fluorouracil and fo ...... the ESPAC-1 and -3(v1) trials

@en

prefLabel

Adjuvant 5-fluorouracil and fo ...... the ESPAC-1 and -3(v1) trials

@ast

Adjuvant 5-fluorouracil and fo ...... the ESPAC-1 and -3(v1) trials

@en

P1433

Q33398018-DC2F6E78-6E28-4EB8-8B79-C0A133422323

P1476

Q33398018-6A0B517C-5BF7-419A-BB21-6C774D13F1BD

P2093

Q33398018-3EE449ED-4D59-4CD4-B1EE-635D34337397

Q33398018-4E1DD141-8097-470D-9FAB-256D43220FBD

Q33398018-57001739-F641-45C8-95F7-6B06CFA13861

Q33398018-6F25CEED-3EBA-4E67-9037-C9CBDBF3D87B

Q33398018-73EBA2C8-813B-4CE4-9718-A68CD3A28A60

Q33398018-8F54DD61-2221-4584-B70F-D9099946A8E2

Q33398018-A42DD0E4-015C-4D05-8BDB-B877E1A331E0

Q33398018-B6DCA3E8-C03D-4AA5-987D-D640CE9F765A

Q33398018-C949534A-328C-45EF-82D2-5E9F0AA7C3AF

P2860

Q33398018-03771E75-0A60-45EE-993F-AAF4A61C41DA

Q33398018-2A3BC156-13D0-48F5-895D-A886FE3B5634

Q33398018-7E9EA818-5130-4244-B2AD-09C992481ACF

Q33398018-94DA83B5-6EE0-4F18-903F-8E5A99FBF5AA

Q33398018-BCAFF3C1-568C-4590-B097-4B34C987A00C

Q33398018-CA4F8183-3FF4-4D18-BD29-F7FC9916BDDB

Q33398018-E12E5481-6236-4FB1-968F-5470F70448D7

Q33398018-E4A16EA8-BD0B-4377-9BB6-C55ABC94DCFF

Q33398018-ED343CFB-9507-47D1-9F37-ABD5DEF06EAC

Q33398018-F0DAFD8B-789E-48C8-B321-B9A59D6AFF3D

P2888

Q33398018-87F4E759-2456-4D8E-ABD0-046869E624E3

P304

Q33398018-E429DD35-E058-4BB9-B39C-A0DE63DBEF69

P31

Q33398018-9BAC2FF3-997D-407B-B79E-379B2F588CC8

Q33398018-f80c5b9e-65ad-4fa1-922e-c088b4014d49

P356

Q33398018-3A59BF9A-358C-4D10-B90A-7E7BFB14E33B

P407

Q33398018-94F4300E-2218-4870-A18B-BAF5EF2E2FD1

P433

Q33398018-E6971DA9-FCFD-4FF7-8B23-25D74E3F16A8

P478

Q33398018-0BB2047D-A6AF-4B15-9FAC-522235E2C438

P50

Q33398018-8E1FD622-B460-471C-A884-41DB38A07DA3

Q33398018-B38D24F0-3819-48AF-961F-E08E59B0010B

P577

Q33398018-A7373749-B516-4A8F-9C5C-BAAB137C5F5B

P5875

Q33398018-96088586-4224-4384-8284-9A47DA22372C

P6179

Q33398018-8A5F29A9-DA87-4EC3-935B-2808E8E6551F

P698

Q33398018-BD0B0CD5-BBE3-42BC-AF27-029CA98E5B03

P932

Q33398018-48A117AB-E48C-4EA7-8C44-D245AA9D67D0

P356

P1433

British Journal of Cancer

P1476

Adjuvant 5-fluorouracil and fo ...... the ESPAC-1 and -3(v1) trials

@en

P2093

C Bassi

http://www.w3.org/2001/XMLSchema#string

C Tudur Smith

http://www.w3.org/2001/XMLSchema#string

D D Stocken

http://www.w3.org/2001/XMLSchema#string

D Smith

http://www.w3.org/2001/XMLSchema#string

E Owen

http://www.w3.org/2001/XMLSchema#string

J P Neoptolemos

http://www.w3.org/2001/XMLSchema#string

M Moore

http://www.w3.org/2001/XMLSchema#string

P Ghaneh

http://www.w3.org/2001/XMLSchema#string

R Padbury

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy.

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of

P2888

P304

246-250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6604838

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Markus Büchler

P577

2009-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23762236

http://www.w3.org/2001/XMLSchema#string

P6179

1009957314

http://www.w3.org/2001/XMLSchema#string

P698

19127260

http://www.w3.org/2001/XMLSchema#string

P932

2625958

http://www.w3.org/2001/XMLSchema#string